Rating Change
Barclays analysts reiterated a Underweight rating on Avantor, Inc. (NYSE:AVTR) on June 24, 2026.
reiterateNYSE:AVTR
Barclays Reiterates Underweight Rating on Avantor, Inc. (AVTR)
Rating Change Barclays analysts reiterated a Underweight rating on Avantor, Inc. (NYSE:AVTR) on June 24, 2026. Market Context Avantor, Inc.
Market Context
Avantor, Inc. operates in the Healthcare sector. The stock currently trades at $9.69 with a market capitalization of $7.8B. The stock has declined 27.9% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Avantor, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Avantor, Inc.
Among the 10 most recent ratings: 1 Buy, 6 Hold, 3 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 24, 2026 | Barclays | Underweight | N/A |
| May 15, 2026 | RBC Capital | Sector Perform | N/A |
| Apr 30, 2026 | Evercore ISI Group | In-Line | N/A |
| Apr 30, 2026 | Citigroup | Neutral | N/A |
| Apr 15, 2026 | Barclays | Underweight | N/A |
Related Tools: Analyst Ratings Dashboard | View AVTR Stock Page
Frequently Asked Questions
What does a Underweight rating mean for AVTR?
A Underweight rating from Barclays reflects the analyst's outlook on Avantor, Inc. (NYSE:AVTR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AVTR forecast page.
